Exiqon Wins Ernst & Young Entrepeneur of the Year Award
News Nov 22, 2005
Exiqon A/S has announced that it has won the Ernst & Young Entrepreneur of the Year award in the category Biotech 2005.
The award is created to identify and acknowledge the successful and entrepreneurial Danish companies.
A minimum growth of 15% in sales as well as growth in staff is among the key nomination criteria.
Exiqon’s ProbeLibrary™ product as well as its miRCURY™ microRNA detection product line were key elements of growth of the company.
"We are very proud to receive this important award," says Lars Kongsbak, President and CEO of Exiqon.
"What we are seeing are the first results of Exiqon’s strategy to develop and market competitive products based on our LNA™ technology."
He adds, "We expect Exiqon’s revenue for 2005 to reach 5-6 million USD."
The Ernst & Young award follows a successful past year where the Exiqon CEO won the award as Biotech Builder of the year, and Exiqon was named among the Top 100 most Innovative companies worldwide by the magazine RedHerring.
CRISPR Reveals New Targets for Promising Cancer DrugsNews
Novel screening method identifies new drug targets that could potentially enhance the effectiveness of PD-1 checkpoint inhibitors, a promising new class of cancer immunotherapy.READ MORE
Potential Barcode Identified for a Form of Alcoholic Liver DiseaseNews
NIAAA-supported researchers have discovered that extracellular vesicles released by liver cells in a mouse model of alcoholic steatohepatitis contain a miRNA signature detectable in the blood.READ MORE
Comments | 0 ADD COMMENT
EMBL Course: Next Generation Sequencing: RNA Sequencing Library Preparation
Apr 23 - Apr 27, 2018
EMBO Practical Course: Microbial Metagenomics: A 360º Approach
Apr 23 - Apr 30, 2018
EMBL Course: Next Generation Sequencing: Whole Genome Sequencing Library Preparation
Apr 16 - Apr 20, 2018
EMBL Course: Introduction to Next Generation Sequencing
Apr 09 - Apr 12, 2018